Showing results (1891-1900 of 2,473) with videos related to

Sort By:
Pageof 248
Cancer Treatment Reviews|April 8, 2016
The immune system and hormone-receptor positive breast cancer: Is it really a dead end?Maria Vittoria Dieci, Gaia Griguolo, Federica Miglietta, et al.
Cancer Treatment Reviews|April 9, 2016
Hormone Receptor/Human Epidermal Growth Factor Receptor 2-positive breast cancer: Where we are now and where we are goingFrancesco Schettini, Giuseppe Buono, Cinzia Cardalesi, et al.
Cancer Treatment Reviews|May 16, 2016
Beta blockers and cancer prognosis - The role of immortal time bias: A systematic review and meta-analysisJanick Weberpals, Lina Jansen, Prudence R Carr, et al.
Cancer Treatment Reviews|July 22, 2017
Therapeutic applications of histone deacetylase inhibitors in sarcomaFan Tang, Edwin Choy, Chongqi Tu, et al.
Cancer Treatment Reviews|July 25, 2017
Treatment decisions in metastatic colorectal cancer - Beyond first and second line combination therapiesA Vogel, R D Hofheinz, S Kubicka, et al.
Cancer Treatment Reviews|September 2, 2017
Healthcare cost of HER2-positive and negative breast tumors in the United States (2012-2035)Francesca Tartari, Matteo Santoni, Mirco Pistelli, et al.
Cancer Treatment Reviews|July 31, 2017
Atypical responses in patients with advanced melanoma, lung cancer, renal-cell carcinoma and other solid tumors treated with anti-PD-1 drugs: A systematic reviewPaola Queirolo, Francesco Spagnolo
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
Cancer Treatment Reviews|June 17, 2016
Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challengesFrancesca Tartari, Matteo Santoni, Luciano Burattini, et al.
Cancer Treatment Reviews|April 24, 2016
The use of circulating tumor cells in guiding treatment decisions for patients with metastatic castration-resistant prostate cancerWendy Onstenk, Willemijn de Klaver, Ronald de Wit, et al.
Pageof 248